Steven Libutti

rdf:langString Steven Libutti

rdf:langString Long Beach, New York, U.S.

rdf:langString National Defense Service Medal ribbon.svg

rdf:langString Public Health Service Bicentennial Unit Commendation Award ribbon.png

rdf:langString USPHS Commissioned Corps Training Ribbon.png

rdf:langString Public Health Service Outstanding Unit Citation ribbon.png

rdf:langString Public Health Service Commendation Medal ribbon.png

rdf:langString Public Health Service Crisis Response Service Award ribbon.png

rdf:langString Global War on Terrorism Service Medal ribbon.png

rdf:langString Steven Kenneth Libutti, M.D., F.A.C.S. (born April 18, 1964) is an American surgeon and scientist. In January 2017, he became the third permanent Director of the Rutgers Cancer Institute of New Jersey, Vice Chancellor for Cancer Programs for Rutgers Biomedical and Health Sciences and the Senior Vice President for Oncology Services for RWJBarnabas Health, the largest health system in New Jersey. He is a tenured Professor of Surgery at the Rutgers Robert Wood Johnson Medical School. Libutti's work on the study of tumor angiogenesis and the tumor microenvironment has led to novel approaches for the treatment of cancer. He is also one of the pioneers of regional and targeted cancer therapy. Libutti was the founding Director of the Montefiore-Einstein Center for Cancer Care, and served as the Associate Director of the Albert Einstein Cancer Center and Vice-Chairman of the Department of Surgery at Montefiore Medical Center and the Albert Einstein College of Medicine from 2009 to 2017. Libutti was a tenured Professor of Surgery and Genetics at the Albert Einstein College of Medicine in the Bronx, New York and a Professor of Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. In September, 2009, Libutti was invested as The Marvin L. Gliedman, M.D. Distinguished Surgeon in the Department of Surgery at Montefiore Medical Center. Libutti is the Editor-in-Chief Emeritus of the Springer Nature journal, Cancer Gene Therapy.